RT @CochraneEyes: New #Cochrane Review: Antimetabolites as an adjunct to #dacryocystorhinostomy for nasolacrimal duct obstruction (#NLDO) h…
Check it out! 🔬🧪 We found that anti-scaring medications success rate of tear duct surgery. 💉👁 Blocked tear ducts cause constant tearing 😢 , but no need to cry anymore!!! 😂 Enjoy my wife’s awesome dance moves! 💃🏻😎 #epiphora https://t.co/NPpFmetRyo https://t
RT @CochraneEyes: New #Cochrane Review: Antimetabolites as an adjunct to #dacryocystorhinostomy for nasolacrimal duct obstruction (#NLDO) h…
New #Cochrane Review: Antimetabolites as an adjunct to #dacryocystorhinostomy for nasolacrimal duct obstruction (#NLDO) https://t.co/nvBEN0yPmD @RCOphth https://t.co/j9LIR61nj9
Antimetabolites as an Adjunct to Dacryocystorhinostomy for Nasolacrimal Duct Obstruction https://t.co/TaRPM43rQ7
鼻涙管狭窄に対するDCRにMitomycin等の上乗せ効果みたコクランレビュー。数年前にコクランに提案したときは優先順位低いとRejectくらったのにいつの間にかレビューされたのね。DCR aloneで有効性75%で、Mitomycinで7-10%ぐらい上乗せぐらいかな。Revisionなら使ってみたいな。 https://t.co/pngHkwEpcA
Our research to minimize human suffering will continue as long as we live and breathe. My latest contribution was published online today. #oculoplastics #DCR #MMC #5FU #dacryocystorhinostomy #epiphora @ASOPRS @NorthShoreWeb @aao_ophth @CochraneEyes https